James Scanlon

2.0k citations
14 papers · 1.4k indexed · 1 hit paper · h-index 9

James Scanlon

13 papers receiving 1.4k citations

Hit Papers

Risk of Natalizumab-Associated Progressive Multifocal Leu...8782012202620162021250500750

Peers

James Scanlon
Comparison fields: 5 of 87
  • Pathology and Forensic Medicine 573
  • Oncology 594
  • Endocrinology, Diabetes and Metabolism 350
  • Immunology 218
  • Neurology 150
Replace Gary Bloomgren with:
Gary Bloomgren United States
Carmen Bozic United States
Raquel Planas Spain
Ilijas Jelčić Switzerland
Ahmad Al‐Sabbagh United States
M. Schipper Netherlands
JC Lee United States
Rafael Arroyo Spain
Gary Birnbaum United States
Esperanza Jordá Spain
James Scanlon relative to Gary Bloomgren United States Gary Bloomgren's profile →
Citations per field
00.5×1.5×
Gary Bloomgren · 1×
Citations per year

Countries citing papers authored by James Scanlon

Since Specialization
Citations

This map shows the geographic impact of James Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Scanlon more than expected).

Fields of papers citing papers by James Scanlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Scanlon. The network helps show where James Scanlon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James Scanlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Scanlon Line = papers co-authored together James Scanlon links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 202110
2 20218
3 201247
4
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathybreakdown →
2012878
5 20128
6 2011102
7 201011
8 200922
9 2009334
10 200913
11 19782
12 19753
13
Self-Reported Health Behavior and Attitudes of Youths 12-17 Years, United States. Data from the National Health Survey, Series 11, Number 147.
19751
14
Decayed,Missing,And filled teeth among children, United States.
19745

About James Scanlon

James Scanlon is a scholar working on Internal Medicine, Periodontics and Psychiatry and Mental health, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Full-Duplex Wireless Communications (3 papers), Polyomavirus and related diseases (3 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers), Migraine and Headache Studies (2 papers), Sepsis Diagnosis and Treatment (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Diabetes Management and Research (2 papers) and Trigeminal Neuralgia and Treatments (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (573 citations), Oncology (594 citations) and Endocrinology, Diabetes and Metabolism (350 citations). James Scanlon has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Sandra Richman, Gary Bloomgren, Tatiana Plavina, Meena Subramanyam, Carmen Bozic, Alfred Sandrock, Christophe Hotermans, Sophia Lee, Susan Goelz and Michael E. Matheny. Their work appears in journals such as Diabetes Care, Headache The Journal of Head and Face Pain, Annals of Pharmacotherapy, New England Journal of Medicine and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026